Rare disease launches require a different approach.
Successful launches are built long before launch day through strong pre-launch planning, cross-functional alignment, meaningful HCP engagement, and a clear content strategy.
In this webinar, we explore how pharmaceutical organizations are approaching rare disease launch strategy today, including the role of Medical Affairs, omnichannel engagement, medical education, and actionable insights in driving launch readiness and long-term impact.
Speaker(s): Daniela Clape, Madelene Borgvall, & Philip Vyt
